Bevacizumab Continuation Versus Treatment Holidays After First-Line Chemotherapy With Bevacizumab in Patients With Metastatic Colorectal Cancer: A Health Economic Analysis of a Randomized Phase 3 Trial (SAKK 41/06)-Reference-Cited by-同舟云学术

Bevacizumab Continuation Versus Treatment Holidays After First-Line Chemotherapy With Bevacizumab in Patients With Metastatic Colorectal Cancer: A Health Economic Analysis of a Randomized Phase 3 Trial (SAKK 41/06)

Published:2016-12 Issue:4 Volume:15 Page:314-320.e2
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Matter-Walstra Klazien^ORCID,Schwenkglenks Matthias,Betticher Daniel,von Moos Roger,Dietrich Daniel,Baertschi Daniela,Koeberle Dieter

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference33 articles.

1. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial;Bennouna;Lancet Oncol,2013

2. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200;Giantonio;J Clin Oncol,2007

3. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

4. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study;Saltz;J Clin Oncol,2008

5. Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study;Tebbutt;J Clin Oncol,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to A. Kurreck et al and M.S. Copur et al;Journal of Clinical Oncology;2022-04-10

2. Economic Evaluation of Monoclonal Antibodies in Metastatic Colorectal Cancer: A Systematic Review;Molecular Diagnosis & Therapy;2021-11

3. Health economic studies of colorectal cancer and the contribution of administrative data: A systematic review;European Journal of Cancer Care;2021-06-21

4. Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer;Future Oncology;2020-11

5. Health Economic Studies of Colorectal Cancer and the Contribution of Administrative Data: a Systematic Review;2020-09-29